Drug recall · November 5, 2014
GLIMEPIRIDE TABLETS recall
Why: Failed Stability Specifications: Micro Labs is recalling two lots due to out of specification results during stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
GLIMEPIRIDE TABLETS, USP 2 mg, a)100 count bottle, (NDC 42571-101-01), b) 500 count Bottle (NDC 42571-101-05), Rx only, Manufactured by: Micro Labs Limited, Goa-403 722, INDIA, Manufactured for: Micro Labs USA, Inc., Princeton, NJ 08540
- Lots / codes
GLBG001 Exp.12/14, GLBG008 Exp. 06/15
- Quantity
- 11,328 bottles
- Company
- Micro Labs Usa, Inc S, Princeton, NJ
- Distribution
- CT, FL, MD, MS, NY
- Initiated
- October 9, 2014 · Voluntary: Firm initiated
- Classified
- October 27, 2014
- Reported
- November 5, 2014
- Ended
- December 29, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Glimepiride
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.